The influence of interleukin (IL)-4, IL-13, and Flt3 ligand on human dendritic cell differentiation from cord blood CD34+ progenitor cells

被引:0
|
作者
Rosenzwajg, M
Camus, S
Guigon, M
Gluckman, JC
机构
[1] Hop La Pitie Salpetriere, CERVI, Immunol Lab, F-75651 Paris 13, France
[2] Fac Med, Ecole Prat Hautes Etud, Lab Biol & Genet Deficits Immunitaires, Paris, France
[3] Fac Med, Ecole Prat Hautes Etud, Lab Immunol Cellulaire, Paris, France
关键词
dendritic cells; differentiation; cytokines; hematopoietic progenitors; cord blood CD34(+) cells;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Culturing cord blood CD34(+) cells with granulocyte-macrophage colony-stimulating factor (GM-CSF) and tumor necrosis factor (TNF)-alpha for 12 days, and stem cell factor (SCF) for 5 days, resulted in a 40- +/- 26-fold expansion in cell numbers, with 38 +/- 20% dendritic cells (DCs). Interleukin (IL)-4 and IL-13, which share properties, were examined first. Adding either one to the former baseline condition beginning on day 0 halved cell growth while the percentage of DCs increased to 60-70%, resulting in unchanged DC yields. Delaying use of IL-4 or IL-13 to day 5 led to 25-fold cell expansion with approximately 80% DC, the yield of which was then twofold over that of baseline control cultures, while numbers of other cells decreased. IL-4 and IL-13 had no additive or antagonistic effect on DC generation. The effect of Flt3 ligand (FL), known to enhance proliferation of hematopoietic progenitors induced by other growth factors, was examined next. FL added alone induced DC in the same manner as SCF. Using both FL and SCF throughout the culture period enhanced total cell recovery fourfold above that of baseline control cultures on day 12 compared with greater than or equal to 2.5-fold if either one was stopped on day 5. When both FL and SCF were used for 12 days, DC recovery was fivefold that of control cultures, whereas it was to three-to 3.5-fold when either one was stopped on day 5. A similar trend was noted for CD15(+) cells, and, to a lesser extent, for CD14(+) cells. Finally, using SCF and FL for 12 days, with IL-4 or IL-13 added from day 5 onwards, led to comparably enhanced cell yields relative to control cultures with approximately 60% DC. These data underline the need to use appropriate cytokine combinations and schedules to optimize generation of DCs from CD34(+) progenitors. Associated with GM-CSF and TNF-alpha, IL-4 or IL-13 promotes differentiation and maturation of DCs over other myeloid cells. Under the same baseline conditions, FL appears to potentiate SCF throughout the culture period, inducing proliferation and development of DC as well as of other myeloid cells.
引用
收藏
页码:63 / 72
页数:10
相关论文
共 50 条
  • [21] Ligand-independent FLT3 activation does not cooperate with MLL-AF4 to immortalize/transform cord blood CD34+ cells
    R Montes
    V Ayllón
    C Prieto
    A Bursen
    C Prelle
    D Romero-Moya
    P J Real
    O Navarro-Montero
    C Chillón
    R Marschalek
    C Bueno
    P Menendez
    Leukemia, 2014, 28 : 666 - 674
  • [22] Ex vivo differentiation of natural killer cells from human umbilical cord blood CD34+ progenitor cells
    Pinho, Maria Joao
    Punzel, Michael
    Sousa, Mario
    Barros, Alberto
    CELL COMMUNICATION AND ADHESION, 2011, 18 (03): : 45 - 55
  • [23] Differentiation and maintenance of mast cells from CD34+ human cord blood cells
    Yoshikubo, T
    Inoue, T
    Noguchi, M
    Okabe, H
    EXPERIMENTAL HEMATOLOGY, 2006, 34 (03) : 320 - 329
  • [24] Interleukin-2 induces development of dendritic cells from cord blood CD34+ cells
    Bykovskaja, SN
    Buffo, MJ
    Bunker, M
    Zhang, HF
    Majors, A
    Lokshin, A
    Levitt, ML
    Jaja, A
    Scalise, D
    Kosiban, D
    Evans, C
    Marks, S
    Shogan, J
    JOURNAL OF LEUKOCYTE BIOLOGY, 1998, 63 (05) : 620 - 630
  • [25] EFFECTS OF HEPATOCYTE GROWTH-FACTOR AND IL-11 ON HUMAN CORD-BLOOD CD34+ PROGENITOR CELLS
    GOFF, JP
    SHIELDS, DS
    MICHALOPOULOS, GK
    GREENBERGER, JS
    EXPERIMENTAL HEMATOLOGY, 1995, 23 (08) : 913 - 913
  • [26] Flt3 ligand promotes myeloid dendritic cell differentiation of human hematopoietic progenitor cells: Possible application for cancer immunotherapy
    Harada, Sachio
    Kimura, Takafumi
    Fujiki, Hiroshi
    Nakagawa, Hitoshi
    Ueda, Yuji
    Itoh, Tsuyoshi
    Yamagishi, Hisakazu
    Sonoda, Yoshiaki
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2007, 30 (06) : 1461 - 1468
  • [27] EFFECTS OF RECOMBINANT HUMAN INTERLEUKIN-4 (IL4) ON MYELOPOIESIS - STUDIES ON PURIFIED CD34+ HEMATOPOIETIC PROGENITOR CELLS
    SNOECK, HW
    LARDON, F
    VANBOCKSTAELE, DR
    KORTHOUT, M
    DEBOCK, R
    PEETERMANS, ME
    EXPERIMENTAL HEMATOLOGY, 1991, 19 (06) : 490 - 490
  • [28] FLT3 ligand preserves the uncommitted CD34+ CD38- progenitor cells during cytokine prestimulation for retroviral transduction
    Nielsen, SD
    Husemoen, LLN
    Sorensen, TU
    Gram, GJ
    Hansen, JES
    JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2000, 9 (05): : 695 - 701
  • [29] FLT3/FLK2 Receptor Expression by Fetal Human Liver and Cord Blood CD34+ Cells and Ligand-mediated Colony Formation
    Sameer Bakhshi
    Hsiao-Nan Hao
    Jiun Zhao
    Nahed Abdel-Haq
    William D Lyman
    Pediatric Research, 1999, 45 : 143 - 143
  • [30] Porcine IL-13 replaces IL-4 in development of swine dendritic cells from peripheral blood
    Bautista, E
    Ferman, GS
    Golde, WT
    FASEB JOURNAL, 2005, 19 (04): : A356 - A356